Literature DB >> 7963520

Involvement of Janus kinases, p52shc, Raf-1, and MEK-1 in the IL-6-induced mitogen-activated protein kinase cascade of a growth-responsive B cell line.

G Kumar1, S Gupta, S Wang, A E Nel.   

Abstract

We have previously shown that the IL-6R in a growth-responsive B cell line, AF10, induces activation of mitogen-activated protein (MAP) kinase. Here we demonstrate the activation of Raf-1 and MEK-1, which act as a MAP kinase kinase kinase and a MAP kinase kinase, respectively, in the MAP kinase cascade induced by IL-6 in AF10 cells. IL-6 also induced tyrosine phosphorylation of the signaling transducing subunit of the IL-6R in AF10 cells, along with tyrosine phosphorylation of the gp130-associated tyrosine protein kinase JAK1 and the adaptor molecule p52shc. Although induction of tyrosine phosphorylation and activation of MAP kinase by IL-6 in a differentiation-responsive B cell line, SKW 6.4, were below the limits of detection, the phorbol ester PMA did activate Raf-1, MEK-1, and MAP kinase without inducing the phosphorylation of gp130, JAKs, or p52shc. These results suggest that JAK kinase family members associated with the IL-6R may participate in the activation of MAP kinase in AF10 cells by way of an adaptor protein and Ras-dependent kinase cascade.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7963520

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Multiple myeloma: increasing evidence for a multistep transformation process.

Authors:  M Hallek; P L Bergsagel; K C Anderson
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

Review 2.  Activating mechanism of CNTF and related cytokines.

Authors:  M Inoue; C Nakayama; H Noguchi
Journal:  Mol Neurobiol       Date:  1996-06       Impact factor: 5.590

3.  Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells.

Authors:  H Kim; T S Hawley; R G Hawley; H Baumann
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

4.  Involvement of Stat3 in interleukin-6-induced IgM production in a human B-cell line.

Authors:  M Faris; N Kokot; N Stahl; A E Nel
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

5.  Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.

Authors:  H Kim; H Baumann
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

6.  Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components.

Authors:  J J Schuringa; L J Jonk; W H Dokter; E Vellenga; W Kruijer
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

7.  EGFR-mediated apoptosis via STAT3.

Authors:  Nicole M Jackson; Brian P Ceresa
Journal:  Exp Cell Res       Date:  2017-04-19       Impact factor: 3.905

Review 8.  IL-6 cytokine family and signal transduction: a model of the cytokine system.

Authors:  M Hibi; K Nakajima; T Hirano
Journal:  J Mol Med (Berl)       Date:  1996-01       Impact factor: 4.599

9.  An association study of polymorphisms in JAK3 gene with lung cancer in the Korean population.

Authors:  Wonbeak Yoo; Hae-Yun Jung; Seungjoon Lim; Jae Sook Sung; Kyong Hwa Park; Jeong Seon Ryu; Sang Won Shin; Jun Suk Kim; Jae Hong Seo; Yeul Hong Kim
Journal:  Cancer Res Treat       Date:  2011-06-30       Impact factor: 4.679

Review 10.  The paradigm of IL-6: from basic science to medicine.

Authors:  Tetsuji Naka; Norihiro Nishimoto; Tadamitsu Kishimoto
Journal:  Arthritis Res       Date:  2002-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.